Jamie L. Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jamie L. Lim has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Helga Eveline de Vries
Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands
2 shared publications - Jack van Horssen
Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands
2 shared publications - Susanne M. A. van der Pol
Department of Molecular Cell Biology and Immunology, Amsterdam Neuroscience, VUmc MS Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
2 shared publications - Bert van Het Hof
Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands
1 shared publication - Flaminia Di Dio
Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands
1 shared publication - Gijs Kooij
Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 7 September 2016
- Published by MDPI AG in Antioxidants
- Vol. 5 (3) , 30
Protandim Protects Oligodendrocytes against an Oxidative Insult
Oligodendrocyte damage and loss are key features of multiple sclerosis (MS) pathology. Oligodendrocytes appear to be particularly vulnerable to reactive oxygen species (ROS) and cytokines, such as tumor necrosis factor-α (TNF), which induce cell death and prevent the differentiation of oligodendrocyte progenitor cells (OPCs). Here, we investigated the efficacy of sulforaphane (SFN), monomethyl fumarate (MMF) and Protandim to induce Nrf2-regulated antioxidant enzyme expression, and protect oligodendrocytes against ROS-induced cell death and ROS-and TNF-mediated inhibition of OPC differentiation. OLN-93 cells and primary rat oligodendrocytes were treated with SFN, MMF or Protandim resulting in significant induction of Nrf2-driven (antioxidant) proteins heme oygenase-1, nicotinamide adenine dinucleotide phosphate (NADPH): quinone oxidoreductase-1 and p62/SQSTM1, as analysed by Western blotting. After incubation with the compounds, oligodendrocytes were exposed to hydrogen peroxide. Protandim most potently promoted oligodendrocyte cell survival as measured by live/death viability assay. Moreover, OPCs were treated with Protandim or vehicle control prior to exposing them to TNF or hydrogen peroxide for five days, which inhibited OPC differentiation. Protandim significantly promoted OPC differentiation under influence of ROS, but not TNF. Protandim, a combination of five herbal ingredients, potently induces antioxidants in oligodendrocytes and is able to protect oligodendrocytes against oxidative stress by preventing ROS-induced cell death and promoting OPC differentiation.
- 7 September 2016
- Published by MDPI AG in Antioxidants
- Vol. 5 (3) , 30
Open AccessProtandim Protects Oligodendrocytes against an Oxidative Insult
Oligodendrocyte damage and loss are key features of multiple sclerosis (MS) pathology. Oligodendrocytes appear to be particularly vulnerable to reactive oxygen species (ROS) and cytokines, such as tumor necrosis factor-α (TNF), which induce cell death and prevent the differentiation of oligodendrocyte progenitor cells (OPCs). Here, we investigated the efficacy of sulforaphane (SFN), monomethyl fumarate (MMF) and Protandim to induce Nrf2-regulated antioxidant enzyme expression, and protect oligodendrocytes against ROS-induced cell death and ROS-and TNF-mediated inhibition of OPC differentiation. OLN-93 cells and primary rat oligodendrocytes were treated with SFN, MMF or Protandim resulting in significant induction of Nrf2-driven (antioxidant) proteins heme oygenase-1, nicotinamide adenine dinucleotide phosphate (NADPH): quinone oxidoreductase-1 and p62/SQSTM1, as analysed by Western blotting. After incubation with the compounds, oligodendrocytes were exposed to hydrogen peroxide. Protandim most potently promoted oligodendrocyte cell survival as measured by live/death viability assay. Moreover, OPCs were treated with Protandim or vehicle control prior to exposing them to TNF or hydrogen peroxide for five days, which inhibited OPC differentiation. Protandim significantly promoted OPC differentiation under influence of ROS, but not TNF. Protandim, a combination of five herbal ingredients, potently induces antioxidants in oligodendrocytes and is able to protect oligodendrocytes against oxidative stress by preventing ROS-induced cell death and promoting OPC differentiation.
- 1 May 2016
- Published by Elsevier in Microvascular Research
- Vol. 105, 61-69
Protective effects of monomethyl fumarate at the inflamed blood–brain barrier
- 1 May 2016
- Published by Elsevier in Microvascular Research
- Vol. 105, 61-69
Protective effects of monomethyl fumarate at the inflamed blood–brain barrier